Funding Rounds
Biosyntia Series B (2022, $11M)
BiosyntiaBiotech company specializing in synthetic biology and metabolic engineering.
Summary
Stage: Series B
Raised Amount: $11.64M
Raised Date: 2022-01-01
Stage: Series B
Raised Amount: $11.64M
Raised Date: 2022-01-01
